[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-337081-105":59,"doc-detail-337081-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","ttk-promotes-her2-breast-cancer-cell-migration-apoptosis-and-resistance-to-targeted-therapy-by-modulating-the-aktmtor-axis","TTK promotes HER2 + breast cancer cell migration, apoptosis, and resistance to targeted therapy by modulating the Akt/mTOR axis","","HER2+ breast cancer is an aggressive malignancy with substantial therapeutic difficulty. Evidence suggests a connection between TTK and multiple tumors, yet the specific role of TTK in HER2+ BRCA and its contribution to targeted-therapy resistance remained unclear. The study investigated TTK knockdown in HER2+ BRCA cells and assessed biological effects and mechanisms using RT-PCR and Western blot. Results showed TTK activates Akt/mTOR to drive proliferation and migration, promotes apoptosis when silenced, and increases sensitivity to pyrotinib.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/ttk-promotes-her2-breast-cancer-cell-migration-apoptosis-and-resistance-to-targeted-therapy-by-modulating-the-aktmtor-axis/337081/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/ttk-promotes-her2-breast-cancer-cell-migration-apoptosis-and-resistance-to-targeted-therapy-by-modulating-the-aktmtor-axis/337081.png","ImageObject",300,407,{"name":92,"@type":93},"Evangeline","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-08","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main biological role of TTK in HER2+ BRCA cells according to the study?","Question",{"text":112,"@type":113},"TTK promotes cell proliferation and migration in HER2+ breast cancer by activating the Akt/mTOR pathway. When TTK is knocked down, cells show reduced proliferation-related behavior and increased apoptotic effects.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was TTK function tested experimentally?",{"text":117,"@type":113},"TTK was knocked down using small interfering RNA transfection in HER2+ BRCA cells. Mechanistic verification used RT-PCR and Western blot assays.",{"name":119,"@type":110,"acceptedAnswer":120},"What effect does TTK knockdown have on apoptosis and cell cycle progression?",{"text":121,"@type":113},"TTK knockdown induced apoptosis and arrested cells in the G1 phase. This supports a tumor-promoting function for TTK in this context.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},337081,1790192567,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},13056703019662,"https://ap-avatar.wpscdn.com/avatar/be000253a8e92610077?_k=1778726343310543188","Journal of Cancer Research and Clinical Oncology (2024) 150:512  \n[https://doi.org/10.1007/s00432-024-06021-9](https://doi.org/10.1007/s00432-024-06021-9)  \nTTK promotes HER2 + breast cancer cell migration, apoptosis, and resistance to targeted therapy by modulating the Akt/mTOR axis  \nShaolin Zhang1,3 · Hua Ding2 · Yongfen Deng4 · Yu Ren1,2 · Fulin Zhou1,5 · Qian Zhang1 · Shu Liu1,2  \nReceived: 5 October 2024 / Accepted: 27 October 2024 / Published online: 26 November 2024 © The Author(s) 2024  \nAbstract  \nBackground HER2 + breast cancer is a malignant neoplasm with a high degree of aggressiveness and therapeutic challenge. In recent years, studies have indicated a strong correlation between TTK and various tumors, though its role in HER2 + BRCA remains unclear.  \nObjectives Studying the biological function of the TTK gene in HER2 + BRCA and its resistance to targeted therapy it provides new ideas for targeted drug research.  \nMethods TTK was knocked down by small interfering RNA transfection, and its biological function in HER2 + BRCA cells was verified, and its mechanism of action was verified by RT-PCR and Western blot.  \nResults The study demonstrated that TTK promoted cell proliferation and migration by activating the Akt/mTOR pathway in HER2 + breast cancer and enhanced the drug sensitivity of BRCA cell lines SKBR3 and BT474 to pyrotinib, in addition, knockdown of TTK induced apoptosis and arrested cells in G1 phase.  \nConclusion Which implies that TTK is an oncogene in HER2 + BRCA and is a valuable research target.  \nKeywords HER2 + breast cancer · Igration · Apoptosis · Drug resistance · Target  \nAbbreviations  \nTTK  \nBRCA  \nTNBC  \nTPBC  \nTCGA  \nUALCAN  \nBCIP  \nOS  \nThreonine tyrosine kinase  \nBreast cancer  \nTriple-negative breast cancer  \nTriple-positivity breast cancer The Cancer Genome Atlas The University of Alabama at Birmingham Cancer  \nBreast Cancer Integrative Platform Overall survival  \n* Shu Liu [drliushu@163.com](drliushu@163.com)  \n1 Department of Clinical Medicine, Guizhou Medical University, Guiyang, China  \n2 Department of Breast Surgery, The Affiliated Hospital of Guizhou Medical University, Guiyang, China  \n3 Department of General Surgery, Dejiang County People′s Hospital, Tongren, Guizhou, China  \n4 Department of Cardiology, Dejiang County People′s Hospital, Tongren, Guizhou, China  \n5 Department of Breast Surgery, GuiYang Maternal and Child Health Care Hospital, Guiyang, China  \nDS Disease specific survival  \nDFS Disease free survival  \nIntroduction  \nCurrently, the most common malignant tumor in women is BRCA(Siegel et al. 2023), with 2.26 million new cases as early as 2020 (Sung et al. 2021), which is increasing year by year and is also the leading cause of cancer deaths in women (J. Qi et al. 2023a, b) . The primary cause of mortality in most patients is the progression, recurrence, and metastasis of the disease following treatment. BRCA originates from breast epithelial cells and can be divided into four subtypes according to molecular typing: LuminalA, LuminalB, HER2 + , and TNBC (Yeo and Guan 2017) . HER2 + BRCA accounts for 15–20% of all breast cancer cases (Curtis et al. 2012); HER2 + BRCA is characterized by rapid growth, aggressiveness, and high mortality. Over half of patients have a survival rate of only five years, with resistance to chemotherapy being a critical factor contributing to disease recurrence, metastasis, and poor prognosis (Slamonet al. 1987) . Pyrotinib is an oral, small-molecule tyrosine kinase inhibitor that has been approved as a first-line drug  \n◂Fig. 1 The expression of TTK in breast cancer was analyzed by relevant databases. A The expression of TTK in different cancer types was analyzed by Sangerbox. B, C The UALCAN ([http://ualcan.path](http://ualcan.path).  \n[uab.edu/](uab.edu/)) database was used to analyze the relationship between TTK expression and tumor stage in normal people and breast cancer patients. D–F The association between TTK gene and survival in HER","cbCaiuTSrsm6Pl0L","https://ap.wps.com/l/cbCaiuTSrsm6Pl0L","pdf",3603767,14,"English","# Abstract\n## Background and objectives\n## Methods and results\n## Conclusion\n# Introduction\n# Figures and experimental validation","[{\"question\":\"What is the main biological role of TTK in HER2+ BRCA cells according to the study?\",\"answer\":\"TTK promotes cell proliferation and migration in HER2+ breast cancer by activating the Akt/mTOR pathway. When TTK is knocked down, cells show reduced proliferation-related behavior and increased apoptotic effects.\"},{\"question\":\"How was TTK function tested experimentally?\",\"answer\":\"TTK was knocked down using small interfering RNA transfection in HER2+ BRCA cells. Mechanistic verification used RT-PCR and Western blot assays.\"},{\"question\":\"What effect does TTK knockdown have on apoptosis and cell cycle progression?\",\"answer\":\"TTK knockdown induced apoptosis and arrested cells in the G1 phase. This supports a tumor-promoting function for TTK in this context.\"}]","TTK promotes HER2 + breast cancer cell migration, apoptosis, and resistance to targeted therapy by modulating the Akt/mTOR axis | PDF",1790017643,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bc3f14ae0a8aa62d4ef38f57426fe5db.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c5edeb053a75d0b09957413ccdda2308.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2a1af69f5f4e6d8de6d111db028b0f90.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6e6942e1ede20fee4c9022c02e7a5e56.webp",980,1301]